Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10885601

Download in:

View as

General Info

PMID
10885601